About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Michigan | 904 Studies

Clinical Trials Breast CancerMichigan

Breast Cancer Clinical Trials in Michigan

Find 904 clinical trials for breast cancer near Michigan. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Michigan

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 904 trials

CompletedGemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast CancerTo determine how long Gemcitabine and Bevacizumab will stop the cancer from growing in patients with advanced breast cancer.NCT00623233·Fayetteville, Arkansas and 15 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study of ADRX-0706 in Select Advanced Solid TumorsThe primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid…NCT06036121·Los Angeles, California and 20 others

CompletedA Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast CancerThe goal of this study was to determine the effect on overall survival and progression free survival by adding iniparib (BSI-201/SAR240550) to the combination of…NCT00938652·Birmingham, Alabama and 101 others

CompletedMammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-SituThis study has been designed to compile information on the efficacy of the MammoSite RTS providing sole radiation therapy for patients with pure DCIS.NCT00586326·Phoenix, Arizona and 11 others

UnknownChemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00408408·Little Rock, Arkansas and 441 others

Active not recruitingPlatinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant ChemotherapyThis randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to capecitabine in treating patients with remaining…NCT02445391·Mobile, Alabama and 1023 others

CompletedMulti-Institutional Transgender & Gender-Diverse Breast Cancer StudyThere is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort.NCT06234488·Los Angeles, California and 21 others

CompletedA Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy…NCT03849469·Encinitas, California and 27 others

RecruitingA Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC).NCT06841354·Mobile, Alabama and 284 others

CompletedStudy to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected CancersThe purpose of this study was to assess the safety, tolerability, and efficacy when combining MK-3475 and INCB024360 in participants with certain cancers.NCT02178722·La Jolla, California and 23 others

Active not recruitingStudy of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesThis study is a first-in-human (FIH), Phase 1/1b, open-label, multicenter dose escalation and dose expansion study to assess the safety, tolerability, pharmacokinetics (PK)…NCT05783622·Duarte, California and 17 others

CompletedCollection of Patient-Reported Symptoms and Performance Status Via the InternetThis pilot clinical trial studies how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with enrolled on Cancer and…NCT00417040·Castro Valley, California and 94 others

CompletedExamining the Relationships Between Sleep, Fatigue, and Pain in Aromatase Inhibitor-treated PatientsAromatase inhibitors are commonly prescribed for treatment of postmenopausal women with breast cancer.NCT01983995·Ann Arbor, Michigan

CompletedA Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1The main purpose of this study is to examine the safety and tolerability of CDX-1401 when given in combination with an immune stimulant (resiquimod) to patients with advanced…NCT00948961·New Haven, Connecticut and 6 others

TerminatedTissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast CancerThrough the investigators' Breast Care Center at the University of Michigan Comprehensive Cancer Center, the investigators treat approximately 75 patients per year with…NCT02455882·Ann Arbor, Michigan

CompletedA Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)The study is designed to compare the clinical benefit following treatment with letrozole in combination with PD-0332991 versus letrozole in combination with placebo in…NCT01740427·Bellflower, California and 304 others

AvailableExpanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009Continued access to treatment for subjects who continue benefit from therapy with gedatolisib in combination with palbociclib, and fulvestrant or letrozole.NCT05134922·Birmingham, Alabama and 4 others

CompletedTestosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentThis randomized phase III trial studies testosterone to see how well it works compared to placebo in treating postmenopausal patients with arthralgia (joint pain) caused by…NCT01573442·Anchorage, Alaska and 528 others

RecruitingA Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid TumorsThe purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies.NCT07318805·Duarte, California and 16 others

CompletedStudy to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsThe primary objective of this study was to determine the safety and tolerability of pamiparib, the maximum tolerated dose (MTD) or maximum administered dose (MAD) for pamiparib…NCT03150810·Grand Rapids, Michigan and 21 others

Page 1 of 46Next

Other Conditions in Michigan

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma